Stories of a Hot Situation by Sommerlund, Julie
 Working Paper 
 
 












 Stem Cells: 







   INSTITUT FOR ORGANISATION OG ARBEJDSSOCIOLOGI 
    Handelshøjskolen i København  
    Solbjerg Plads 3 
    2000 Frederiksberg 
    Tlf: 38 15 28 15     Fax: 38 15 28 28 
 
Stem Cells: Stories of a Hot Situation 
 
Julie Sommerlund 
Department of Organization & Industrial Sociology 





In his influential essay on markets, An essay on framing and overflowing (1998), 
Michel Callon writes that “the growing complexity of industrialized societies 
[is] due in large part to the movements of the technosciences, which are causing 
connections and interdependencies to proliferate”. This paper is about tech-
noscience, and about the proliferation of connections and interdependencies 
created by it.  
 
More specifically, the paper is about stem cells. Biotechnology in general has the 
power to capture the imagination. Within the field of biotechnology nothing 
seems more provocative and tantalizing than stem cells, in research, in medi-
cine, or as products.  
Already, I have hinted at one cause of the stem cells´ powers of fascination: 
the fact that it is equally research-subject, product, therapeutic medicine, but 
also myth (stem cell), and much else. The stem cell is a tiny object with the ca-
pacity to link many networks that was previously unlinked - a tiny object able to 
take on many shapes.  
 
In the vocabulary of Michel Callon, whom I quoted above, the point is that the 
framing of a market (or any other `field´/`sphere´, I would argue) is costly and 
rare, and that overflows are the norm rather than the exception. Callon´s ana-
lytic vocabulary is simple and effective, and allows you to rapidly make mean-
ingful points about very complex phenomena. The terms picked up from Cal-
lon´s text that are most central here text, are the following.  
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Framing/overflowing:  
When creating a market, actors try to `frame´ it, thus making it context-free, and 
shielded from the outside world. However, writes Callon, frames will always 
leak, or overflow. The very idea of the frame relies on the context, from which it 
tries to free itself. If the inside of a frame was really cut off from the context the 
inside would loose all legitimacy and efficiency. Scientific language would be-
come meaningless, standardized equipment would disappear, etc. Overflows 
are the rule, rather than the exception.  
Hot/Cold Situations:  
As mentioned, overflows are the rule in all framing-processes. But overflows 
can have different meanings. Callon makes a distinction between `cold´ and 
`hot´ situations, which indicates situations characterized by different types of 
overflows.  
In cold situations there is wide-spread agreement about overflows: “Actors 
are identified, interests are stabilized, preferences can be expressed, responsibili-
ties are acknowledged and accepted.” (1998: 261)  












The case of stem cells seems to be exceptionally `hot´, so hot that an all-
encompassing description is impossible – and not only for pragmatic reasons. 
The situation moves so fast, that such a description would always be outdated. 
Instead, I have chosen to tell stories and anecdotes of “the proliferation of con-
nections and interdependencies”. In other words, this paper tries to offer some 
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angles on the hot situation, looking to specify different types of framing, over-
flows, agents and interests. The stories will be mainly Danish, but as Callon 
rightly notices, in hot situations “the local and the global are in constant interac‐
tions” (262), and therefore my framing the scene as strictly national would be fu-
tile.  
1. Story:  
Classifications and practices: How legal became illegal and existent became non-existent 
  
Stem cells are classified in (at least) three different ways, the three systems to-
gether constituting a complex 3-dimensional matrix: 
 
First, there are the three developmental stages of the cell that are becoming in-
creasingly known to the public: the embryonic stem cell, the naval-cord stem 
cell, and the adult stem cell.  
It is legal to do research on stem cells from up to 2 week-old embryos. After 
that the practice becomes illegal, which makes the embryonic stem cell non-
existent (as a research subject) after the 2 first weeks. The stem cell re-emerges 
approximately 8½ months later as a naval-cord stem cell.  The naval-cord stem 
cell exists for fifteen minutes after the birth of a child. After that the blood co-
agulates, and the stem cells are no more. The stem cell next reappears as an 
adult stem cell, found in the bodies of adults and children, for instance in blood 
marrow, producing new blood cells.  
In a research-specific frame, the stem cell exists only very briefly in its potent 
early stages. The first gestalt, the embryonic stem cell, is taken out of existence 
by law, whereas the second gestalt, the naval-cord stem cell, is eclipsed by the 
blood’s immanent characteristics (coagulation). The brevity of the early stem 
cells´ existence makes the harvesting of them a central crux. This will become 
obvious in the stories to come.   
 
Second, there is a differentiation made on the basis of the specificity of the stem 
cell. The differentiation is made between totopotent stem cells, pluripotent stem 
cells and multipotent stem cells.  
Totopotent stem cells can become any human cell, which means that these 
are the earliest cells of the embryo. Some argue that it is in fact only the fertil-
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ized egg that can rightfully be referred to as totopotent. Pluripotent stem cells 
can become different cells in different types of tissues, while multipotent stem 
cells can become different cells of the same tissues.  
  This classification is in some ways coincident with the classification above, 
but it has central differences as well: The classification of toto-, pluri- and multi-
potent stem cells is not intrinsically connected to the development the `host-
organism´. For instance, experiments are being made, trying to have multipotent 
stem cells (for instance from adults) develop `backwards´ and become pluripo-
tent stem cells.   
  
Third, is a developmental differentiation – not an organism-specific develop-
ment, as was the case above, but a cell-specific development. This is a differen-
tiation between stem cells, progenitors and precursors. Progenitors and precur-
sors are not considered stem cells, but immature cells that are maturing into one 
specific cell type. 
The distinction between stem cells and the different types of immature cells 
is relatively new. This makes the differentiation between stem cells, progenitors 
and precursors a historical as well as a developmental one:   
The term “stem cell”, and the differentiation between stem cells, progenitors 
and precursors, has been around for a long time in some parts of the scientific 
community, for instance within haematology, but is rather new in others.  In 
neurobiology in the 90s, for instance, scientists worked with foetal tissues that 
contained all the different types of immature cells – stem cells, progenitors and 
precursors. But it was presumed that the tissues mainly contained precursors. It 
was not until later that it was discovered that these tissues did in fact contain 
actual stem cells.  
Until then, the work of transplanting foetal tissues was described using the 
term `precursor cells´, not `stem cells´. It was not until the simultaneous discov-
ery of the presence of stem cells, and the increasing use of the term stem cells in 
the public, that the use of foetal tissues were made into a problem. Until then, 
says a researcher in the biotech-industry, quoted from memory: “it was rela-
tively unproblematic to get permission to perform this kind of research, using 
tissues from aborted foetuses. These foetuses were typically more than 6 weeks 
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old. Now, it is heavily disputed whether we can use fertilized eggs for re-
search”.  
  When the term `stem cell´ connected the last and the first classification sys-
tem described here, it also meant that the research practice described by the re-
searcher above became connected to a political practice – i.e. the prohibition 
against using stem cells from embryos more than 2 weeks old. The cells from 
older foetuses that had been used for research suddenly disappeared. This dis-
appearing act also meant that working with stem cells from 6 – 10 week old 
aborted foetuses went from being ordinary practice to being illegal.   
2. Story: 
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5. Story: 




















































Interestingly, the doctors speaking on the subject in the media are unanimously 
against the private bio banks. They are arduously trying to cut the connection 
between their work with stem cells and the service sold by the bio banks. At the 
same time, what the bio banks are selling is the hope that the same doctors will 
come up with miraculous cures against diseases. And if this possibility is even 
remotely possible, what parent would say no? As indicated in the quote from 
the young mother; only a poor one.  
 Thus, the doctors try to keep the frames of medical research apart from the 
frame of bio banking-market, while the bio banks try to connect the two.  
 
But the complications do not stop here: The bio banks’ attempts to associate 
themselves with the frame of serious medical research only goes so far. The fol-
lowing is the story of how a bio bank actually claimed that what they were sell-
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